Ubs Group Ag Gritstone Bio, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 681 shares of GRTS stock, worth $20. This represents 0.0% of its overall portfolio holdings.

Number of Shares

681

Previous 84,815 99.2%

Holding current value

$20

Previous $52,000 100.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.45 - $0.71 $37,860 - $59,735	-84,134 Reduced 99.2%	681 $0
Q2 2024 Aug 13, 2024	SELL	$0.62 - $2.35 $60,873 - $230,730	-98,183 Reduced 53.65%	84,815 $52,000
Q1 2024 May 13, 2024	SELL	$1.96 - $2.9 $28,753 - $42,543	-14,670 Reduced 7.42%	182,998 $470,000
Q4 2023 Feb 09, 2024	SELL	$1.28 - $2.85 $87,371 - $194,538	-68,259 Reduced 25.67%	197,668 $403,000
Q3 2023 Nov 09, 2023	SELL	$1.19 - $2.26 $1,662 - $3,157	-1,397 Reduced 0.52%	265,927 $457,000
Q2 2023 Aug 11, 2023	BUY	$1.66 - $3.03 $90,289 - $164,804	54,391 Added 25.54%	267,324 $521,000
Q1 2023 May 12, 2023	SELL	$2.13 - $3.74 $6,051 - $10,625	-2,841 Reduced 1.32%	212,933 $591,000
Q4 2022 Feb 08, 2023	SELL	$2.17 - $3.92 $10,081 - $18,212	-4,646 Reduced 2.11%	215,774 $744,000
Q3 2022 Nov 10, 2022	BUY	$2.46 - $4.75 $76,038 - $146,822	30,910 Added 16.31%	220,420 $566,000
Q2 2022 Aug 10, 2022	SELL	$1.77 - $4.34 $1,256 - $3,081	-710 Reduced 0.37%	189,510 $459,000
Q1 2022 May 16, 2022	SELL	$4.03 - $12.19 $636,490 - $1.93 Million	-157,938 Reduced 45.36%	190,220 $784,000
Q4 2021 Feb 14, 2022	BUY	$8.76 - $13.71 $2.21 Million - $3.45 Million	251,984 Added 262.01%	348,158 $4.48 Million
Q3 2021 Nov 15, 2021	BUY	$6.41 - $13.54 $613,353 - $1.3 Million	95,687 Added 19648.25%	96,174 $1.04 Million
Q2 2021 Aug 13, 2021	SELL	$8.13 - $10.2 $68,202 - $85,567	-8,389 Reduced 94.51%	487 $5,000
Q1 2021 May 12, 2021	BUY	$4.07 - $27.11 $14,595 - $97,216	3,586 Added 67.79%	8,876 $84,000
Q4 2020 Feb 11, 2021	BUY	$2.57 - $4.22 $13,595 - $22,323	5,290 New	5,290 $21,000
Q3 2020 Nov 12, 2020	SELL	$2.63 - $8.09 $16,708 - $51,395	-6,353 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$5.69 - $8.17 $19,220 - $27,598	-3,378 Reduced 34.71%	6,353 $42,000
Q1 2020 May 01, 2020	SELL	$5.47 - $11.3 $102,923 - $212,620	-18,816 Reduced 65.91%	9,731 $57,000
Q4 2019 Feb 14, 2020	BUY	$7.07 - $11.61 $58,285 - $95,712	8,244 Added 40.6%	28,547 $256,000
Q3 2019 Nov 14, 2019	BUY	$8.45 - $12.28 $133,518 - $194,036	15,801 Added 350.98%	20,303 $175,000
Q2 2019 Aug 14, 2019	BUY	$9.2 - $15.7 $34,058 - $58,121	3,702 Added 462.75%	4,502 $50,000
Q1 2019 May 14, 2019	SELL	$9.97 - $18.96 $22,362 - $42,527	-2,243 Reduced 73.71%	800 $11,000
Q4 2018 Feb 14, 2019	BUY	$11.61 - $31.1 $35,329 - $94,637	3,043 New	3,043 $47,000

Others Institutions Holding GRTS

# of Institutions

Shares Held

35.4M

Call Options Held

395K

Put Options Held

132K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account